Stay updated on Dara-VCd vs VTd, Maintenance with IXA Clinical Trial

Sign up to get notified when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 is displayed, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:15:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added related topics links for Multiple Myeloma and MedlinePlus Genetics on the study page.
    Difference
    0.2%
    Check dated 2026-03-04T15:28:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added related-topic links for Multiple Myeloma and MedlinePlus Genetics and updated the page revision to v3.4.2. Removed the government funding notice and the previous revision notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T09:53:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with status details and links, and updated the site version to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:36:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and metadata updates include showing the glossary, capitalization tweaks to 'Last Update Submitted that Met QC Criteria', updated No FEAR Act Data wording, and a revision bump to v3.4.0. These changes do not affect core study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:13:55.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Deleting 'Multiple myeloma' removes the core disease focus from the related topics. Removing 'MedlinePlus Genetics' eliminates a relevant educational resource for patients and researchers.
    Difference
    0.2%
    Check dated 2026-01-21T03:14:12.000Z thumbnail image

Stay in the know with updates to Dara-VCd vs VTd, Maintenance with IXA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-VCd vs VTd, Maintenance with IXA Clinical Trial page.